Loading...
XTAI
4108
Market cap89mUSD
Dec 05, Last price  
14.10TWD
1D
0.71%
1Q
-15.06%
Jan 2017
-53.85%
IPO
-65.30%
Name

Phytohealth Corp

Chart & Performance

D1W1MN
XTAI:4108 chart
P/E
—
P/S
18.24
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.32%
Rev. gr., 5y
9.97%
Revenues
154m
-5.49%
99,193,000107,904,000155,092,000177,711,000144,988,00090,732,00020,978,00025,021,00053,996,000107,483,00095,485,00091,810,000168,936,000135,465,000162,489,000153,562,000
Net income
-74m
L+56.00%
-267,053,000-215,119,000-170,071,000-103,794,000-182,964,000-321,702,000-203,500,000-194,516,000-206,349,000-182,476,000-170,927,000-118,655,000-78,021,000-115,035,000-47,117,000-73,501,000
CFO
-50m
L-8.47%
-107,148,000-193,063,000-171,088,000-164,368,000-123,180,000-33,743,000-131,217,000-756,870,000-151,520,000-141,435,000-121,446,000-147,866,000-68,239,000-59,948,000-54,772,000-50,134,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.
URL
https://www.phytohealth.com.tw/zh-Hant
IPO date
May 07, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT